Arteris (US.AIP)
Capital Allocation Audit · Period: 2019 – 2026
Key Metrics
US.AIP · YoY: 2026 Q1 vs 2025 Q1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 104.2% | ↑ |
| ROE | -307.2% | → |
| Cash Conversion | - | → |
| D/E Ratio | 2.60 | → |
| Gross Margin | 85.8% | ↓ |
US.AIP (Arteris) | YoY: 2026 Q1 vs 2025 Q1 Metric Value YoY ----------------------------- FCF Conversion 104.2% ↑ ROE -307.2% → Cash Conversion - → D/E Ratio 2.60 → Gross Margin 85.8% ↓
Key Metrics
US.AIP (Arteris) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY-----------------------------FCF Conversion 104.2% ↑ROE -307.2% →Cash Conversion - →D/E Ratio 2.60 →Gross Margin 85.8% ↓Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies